Dopamine Uptake InhibitorsBenztropineNomifensineDopamineDopamine Plasma Membrane Transport ProteinsCocaineReceptors, Dopamine D2Neurotransmitter Uptake InhibitorsTropanesPiperazinesDopamine AntagonistsReceptors, Dopamine D1MazindolMembrane Transport ProteinsReceptors, DopamineDopamine AgonistsNortropanesReceptors, Dopamine D3Corpus StriatumDopamine AgentsNorepinephrine Plasma Membrane Transport ProteinsNerve Tissue ProteinsSynaptosomesAmphetamineAdrenergic Uptake InhibitorsMembrane GlycoproteinsNucleus AccumbensRats, Sprague-DawleyNeostriatumMethamphetamineReceptors, Dopamine D5MethylphenidateCarrier ProteinsVesicular Monoamine Transport ProteinsCaudate NucleusBiological TransportSerotoninGABA Uptake InhibitorsMicrodialysisDose-Response Relationship, DrugSerotonin Plasma Membrane Transport ProteinsMotor ActivityMembrane Transport ModulatorsDopamine beta-HydroxylasePutamenBehavior, AnimalBrainSubstantia NigraSerotonin Uptake InhibitorsRacloprideATP-Binding Cassette TransportersCentral Nervous System StimulantsLobelineFluoxetineQuinpiroleTetrabenazineMesencephalonDesipramineBiogenic MonoaminesNipecotic AcidsNorepinephrineBenzazepinesTyrosine 3-MonooxygenaseCocaine-Related DisordersDopaminergic Neurons1-Methyl-4-phenylpyridiniumZimeldineNeuronsStereotyped BehaviorDrug InteractionsSelf AdministrationBrain ChemistryLevodopaSalicylamidesOrganic Anion TransportersSulpirideTomography, Emission-Computed, Single-PhotonClomipramineHaloperidolHomovanillic AcidBinding, CompetitiveTritiumKineticsReserpineSymporters3,4-Dihydroxyphenylacetic AcidOxidopamineTime FactorsDextroamphetamineParkinsonian DisordersAmphetaminesIodine RadioisotopesSerotonin AntagonistsVentral Tegmental AreaApomorphineN-Methyl-3,4-methylenedioxyamphetaminealpha-MethyltyrosinePargylineRadiopharmaceuticals1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine